Ksg. Jie et al., VITAMIN-K INTAKE AND OSTEOCALCIN LEVELS IN WOMEN WITH AND WITHOUT AORTIC ATHEROSCLEROSIS - A POPULATION-BASED STUDY, Atherosclerosis, 116(1), 1995, pp. 117-123
Protein-bound gamma-carboxyglutamate (Gla) has been demonstrated in ca
lcified atherosclerotic plaques. Vitamin K is required for the formati
on of Cia-residues. As the biological activity of Cia-proteins appears
to be strictly dependent on the presence of the Cia-residues, vitamin
K status may be an important factor in the development and progressio
n of atherosclerotic calcifications. We studied the association of vit
amin K status, as assessed by nutritional vitamin K intake and the mea
surements of two circulating immunoreactive osteocalcin (irOC) fractio
ns, with aortic atherosclerosis in a population-based study of 113 pos
tmenopausal women. Women with calcified lesions (n = 34) had a 42.9 mu
g lower mean age-adjusted dietary vitamin K intake/day (95% C.I. -6.6
to 92.5) than those without calcifications (n = 79). Atherosclerotic
women had higher irOC levels with a low affinity for hydroxyapatite (i
rOC(free)): age-adjusted difference of 0.32 ng/ml (95% C.I. 0.03 to 0.
61). In addition, the high affinity irOC levels expressed as a percent
age (hydroxyapatite binding capacity, HBC) were 5.12% (95% C.I. 1.32 t
o 8.92) lower in women with calcifications. Our study indicates that w
omen with aortic atherosclerosis have an impaired vitamin K status as
reflected by a lower nutritional vitamin K intake, an increased irOC(f
ree) level and a reduced HBC level. An impaired vitamin K status in su
bjects with atherosclerosis is compatible with the view that vitamin K
or Gla-containing proteins are involved in the development of calcifi
cation of the vessel wall.